In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Monte Rosa Therapeutics Inc (NASDAQ: GLUE) was $5.55 for the day, up 0.91% from the previous closing price of $5.50. In other words, the price has increased by $0.91 from its previous closing price. On the day, 0.69 million shares were traded.
Ratios:
Our analysis of GLUE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.03 and its Current Ratio is at 6.03. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $11 from $14 previously.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $11.
Wells Fargo Upgraded its Equal Weight to Overweight on January 03, 2023, while the target price for the stock was maintained at $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 28 ’24 when Versant Venture Capital VI, L. sold 89,990 shares for $9.66 per share. The transaction valued at 869,240 led to the insider holds 2,007,948 shares of the business.
Versant Venture Capital VI, L. sold 67,905 shares of GLUE for $621,801 on Oct 29 ’24. The 10% Owner now owns 1,573,453 shares after completing the transaction at $9.16 per share. On Oct 28 ’24, another insider, Wallace Owen B., who serves as the Officer of the company, bought 20,000 shares for $12.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 22.78 while its Price-to-Book (P/B) ratio in mrq is 1.66.
Stock Price History:
Over the past 52 weeks, GLUE has reached a high of $12.40, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is -12.65%, while the 200-Day Moving Average is calculated to be -6.12%.
Shares Statistics:
A total of 61.38M shares are outstanding, with a floating share count of 45.95M. Insiders hold about 25.21% of the company’s shares, while institutions hold 80.32% stake in the company.
